Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. Innovation is increasingly intertwined with advancements in ...
In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...
Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. Traditional methods, while advancing, are hitting limits in tackling the complexities ...
The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...
The CSIR is producing the active ingredient of an expensive pain medication at its new FuturePharma facility in Pretoria, the ...
K-12 education can benefit from AI’s synthesis of research and curriculum standards. Industrial Research Looks Into the Future, and You Can Too! A report out this month from IRI–one of a handful of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results